Published in Proc Natl Acad Sci U S A on October 10, 2005
The role of human movement in the transmission of vector-borne pathogens. PLoS Negl Trop Dis (2009) 4.24
Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am J Trop Med Hyg (2007) 3.29
River blindness: a success story under threat? PLoS Med (2006) 2.55
Bayesian geostatistical prediction of the intensity of infection with Schistosoma mansoni in East Africa. Parasitology (2006) 2.19
The applications of model-based geostatistics in helminth epidemiology and control. Adv Parasitol (2011) 1.76
Mapping helminth co-infection and co-intensity: geostatistical prediction in ghana. PLoS Negl Trop Dis (2011) 1.27
Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin Infect Dis (2014) 1.25
Estimated effects of projected climate change on the basic reproductive number of the Lyme disease vector Ixodes scapularis. Environ Health Perspect (2014) 1.24
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Proc Natl Acad Sci U S A (2009) 1.21
Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasit Vectors (2015) 1.14
Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis. PLoS Negl Trop Dis (2013) 1.13
The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis (2009) 1.12
Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae. PLoS Negl Trop Dis (2013) 1.02
Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality. PLoS Negl Trop Dis (2012) 1.02
Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections. Parasit Vectors (2014) 1.01
Evidence of suppression of onchocerciasis transmission in the Venezuelan Amazonian focus. Parasit Vectors (2016) 0.93
Individual predisposition, household clustering and risk factors for human infection with Ascaris lumbricoides: new epidemiological insights. PLoS Negl Trop Dis (2011) 0.92
Onchocerciasis transmission in Ghana: biting and parous rates of host-seeking sibling species of the Simulium damnosum complex. Parasit Vectors (2014) 0.90
The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data. Parasit Vectors (2015) 0.90
Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors. PLoS Negl Trop Dis (2015) 0.89
In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination. Proc Natl Acad Sci U S A (2006) 0.87
Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal. Epidemics (2017) 0.85
Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme. PLoS Negl Trop Dis (2015) 0.83
Modeling targeted ivermectin treatment for controlling river blindness. Am J Trop Med Hyg (2006) 0.81
Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis. BMC Med (2016) 0.81
Time series analysis of onchocerciasis data from Mexico: a trend towards elimination. PLoS Negl Trop Dis (2013) 0.81
Factors Associated with Ivermectin Non-Compliance and Its Potential Role in Sustaining Onchocerca volvulus Transmission in the West Region of Cameroon. PLoS Negl Trop Dis (2016) 0.78
Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology (1996) 3.80
"Neglected" diseases but unrecognised successes--challenges and opportunities for infectious disease control. Lancet (2004) 2.64
Thinking beyond deworming. Lancet (2004) 2.64
A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ (1986) 2.51
Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol (2003) 2.13
Control of onchocerciasis today: status and challenges. Trends Parasitol (2001) 1.84
ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed (1990) 1.70
Herd immunity to helminth infection and implications for parasite control. Nature (1985) 1.52
Theoretical approach to the epidemiology of onchocerciasis in Guatemala. Jpn J Med Sci Biol (1982) 1.48
Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet (2004) 1.47
Variations in the prevalence and intensity of microfilarial infections by age, sex, place and time in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg (1983) 1.46
Acquired immunity and epidemiology of Schistosoma haematobium. Nature (1991) 1.44
Studies on onchocerciasis in the United Cameroon Republic. II. Comparison of onchocerciasis in rain-forest and Sudan-savanna. Trans R Soc Trop Med Hyg (1974) 1.34
Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments. Trans R Soc Trop Med Hyg (1997) 1.33
Population biology of human onchocerciasis. Philos Trans R Soc Lond B Biol Sci (1999) 1.20
[Latency period in onchocerciasis]. Bull World Health Organ (1980) 1.15
On the interpretation of age-intensity profiles and dispersion patterns in parasitological surveys. Parasitology (2003) 1.04
The population dynamics of Onchocerca volvulus in the human host. Trop Med Parasitol (1993) 1.03
Density-dependent parasite establishment suggests infection-associated immunosuppression as an important mechanism for parasite density regulation in onchocerciasis. Trans R Soc Trop Med Hyg (2003) 1.00
Onchocerciasis in Guatemala. Epidemiology in fincas with various intensities of infection. Am J Trop Med Hyg (1981) 1.00
Transmission intensity and the patterns of Onchocerca volvulus infection in human communities. Am J Trop Med Hyg (2002) 0.98
Description of a computer model of forest onchocerciasis transmission and its application to field scenarios of vector control and chemotherapy. Ann Trop Med Parasitol (1993) 0.93
Factors affecting the differential susceptibility of males and females to onchocerciasis. Acta Leiden (1990) 0.92
Human onchocerciasis in the Amazonian area of southern Venezuela: spatial and temporal variations in biting and parity rates of black fly (Diptera: Simuliidae) vectors. J Med Entomol (2001) 0.92
Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon IV. The different exposure to Simulium bites and transmission of boys and girls and men and women, and the resulting manifestations of onchocerciasis. Ann Trop Med Parasitol (1987) 0.91
The relationships between the burden of adult parasites, host age and the microfilarial density in human onchocerciasis. Int J Parasitol (2004) 0.89
Onchocerciasis in San Vicente Pacaya, Guatemala. Am J Trop Med Hyg (1979) 0.88
The effect of pregnancy on Wuchereria bancrofti microfilarial load in humans. Parasitology (1999) 0.87
Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon III. Infection rates of the Simulium vectors and Onchocerca volvulus transmission potentials. Ann Trop Med Parasitol (1987) 0.86
Amazonian onchocerciasis: parasitological profiles by host-age, sex, and endemicity in southern Venezuela. Parasitology (2000) 0.86
Onchocerciasis in the Amazonian focus of southern Venezuela: altitude and blackfly species composition as predictors of endemicity to select communities for ivermectin control programmes. Trans R Soc Trop Med Hyg (1999) 0.83
Onchocerciasis hyperendemic in the Unturán Mountains: the value of recombinant antigens in describing a new transmission area in southern Venezuela. Trans R Soc Trop Med Hyg (1999) 0.79
Exponential growth in age-structured two-sex populations. Math Biosci (1999) 0.78
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet (2012) 15.74
Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet (2002) 7.25
Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med (2010) 5.71
River blindness: a success story under threat? PLoS Med (2006) 2.55
A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis (2012) 2.28
Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection. Elife (2013) 2.17
The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab (2013) 2.17
A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis (2012) 2.09
Modelling the impact of vector control interventions on Anopheles gambiae population dynamics. Parasit Vectors (2011) 1.99
Change in salt intake affects blood pressure of chimpanzees: implications for human populations. Circulation (2007) 1.99
Does gestation vary by ethnic group? A London-based study of over 122,000 pregnancies with spontaneous onset of labour. Int J Epidemiol (2004) 1.97
Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis (2008) 1.88
A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl Trop Dis (2012) 1.78
Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol (2012) 1.76
Progression of Plasmodium berghei through Anopheles stephensi is density-dependent. PLoS Pathog (2007) 1.71
Th2 cytokines are associated with reduced worm burdens in a human intestinal helminth infection. J Infect Dis (2003) 1.64
Micro-epidemiology of urinary schistosomiasis in Zanzibar: Local risk factors associated with distribution of infections among schoolchildren and relevance for control. Acta Trop (2007) 1.61
Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys. PLoS Negl Trop Dis (2009) 1.58
Impact of ivermectin on onchocerciasis transmission: assessing the empirical evidence that repeated ivermectin mass treatments may lead to elimination/eradication in West-Africa. Filaria J (2003) 1.56
Estimating household and community transmission of ocular Chlamydia trachomatis. PLoS Negl Trop Dis (2009) 1.52
Systematic review of worldwide variations of the prevalence of wheezing symptoms in children. Environ Health (2008) 1.48
Anopheles mortality is both age- and Plasmodium-density dependent: implications for malaria transmission. Malar J (2009) 1.47
Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl Trop Dis (2007) 1.44
Radiation: a dose of the bomb. Nature (2003) 1.40
Early growth and adult respiratory function in men and women followed from the fetal period to adulthood. Thorax (2006) 1.36
Onchocerciasis Control: Vision for the Future from a Ghanian perspective. Parasit Vectors (2009) 1.33
A research agenda for helminth diseases of humans: towards control and elimination. PLoS Negl Trop Dis (2012) 1.26
Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. BMJ (2004) 1.26
Trachoma: transmission, infection, and control. Lancet Infect Dis (2007) 1.25
Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness. J Infect Dis (2008) 1.24
Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship. Int J Radiat Oncol Biol Phys (2012) 1.24
The epidemiology and control of urinary schistosomiasis and soil-transmitted helminthiasis in schoolchildren on Unguja Island, Zanzibar. Trans R Soc Trop Med Hyg (2009) 1.22
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Proc Natl Acad Sci U S A (2009) 1.21
T helper cell type 2 responsiveness predicts future susceptibility to gastrointestinal nematodes in humans. J Infect Dis (2004) 1.21
Population-based risks of CNS tumors in survivors of childhood cancer: the British Childhood Cancer Survivor Study. J Clin Oncol (2010) 1.20
Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology (2008) 1.18
Non-targeted effects of ionising radiation--implications for low dose risk. Mutat Res (2012) 1.18
ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer (2013) 1.18
Radiation and the risk of chronic lymphocytic and other leukemias among chornobyl cleanup workers. Environ Health Perspect (2012) 1.17
Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach. Bull World Health Organ (2003) 1.16
Comment on "dose-responses from multi-model inference for the non-cancer disease mortality of atomic bomb survivors" (Radiat. Environ. Biophys (2012) 51:165-178) by Schöllnberger et al. Radiat Environ Biophys (2013) 1.16
Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control. Filaria J (2004) 1.16
Allergen-specific IgE and IgG4 are markers of resistance and susceptibility in a human intestinal nematode infection. Microbes Infect (2005) 1.13
Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis. PLoS Negl Trop Dis (2013) 1.13
Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species). J Infect Dis (2005) 1.12
The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study. PLoS Negl Trop Dis (2013) 1.09
Age- and infection intensity-dependent cytokine and antibody production in human trichuriasis: the importance of IgE. J Infect Dis (2002) 1.09
Parasite genetic differentiation by habitat type and host species: molecular epidemiology of Schistosoma japonicum in hilly and marshland areas of Anhui Province, China. Mol Ecol (2009) 1.08
Comment on "Use of A-bomb survivor studies as a basis for nuclear worker compensation". Environ Health Perspect (2003) 1.08
Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp. Am J Trop Med Hyg (2008) 1.08
Onchocerca-Simulium interactions and the population and evolutionary biology of Onchocerca volvulus. Adv Parasitol (2009) 1.07
Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis (2013) 1.05
RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer (2013) 1.04
Associations between pre-pregnancy obesity and asthma symptoms in adolescents. J Epidemiol Community Health (2011) 1.04
Task-based measures of image quality and their relation to radiation dose and patient risk. Phys Med Biol (2015) 1.03
Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events. Am J Trop Med Hyg (2009) 1.03
Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae. PLoS Negl Trop Dis (2013) 1.02
Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality. PLoS Negl Trop Dis (2012) 1.02
Modelling the impact of ivermectin on River Blindness and its burden of morbidity and mortality in African Savannah: EpiOncho projections. Parasit Vectors (2014) 1.01
Population genetics of Schistosoma japonicum within the Philippines suggest high levels of transmission between humans and dogs. PLoS Negl Trop Dis (2008) 1.00
Targeting antibiotics to households for trachoma control. PLoS Negl Trop Dis (2010) 1.00
P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol Biochem Parasitol (2007) 1.00
Density dependence and the control of helminth parasites. J Anim Ecol (2006) 0.99
Density-dependent host choice by disease vectors: epidemiological implications of the ideal free distribution. Trans R Soc Trop Med Hyg (2006) 0.99
A research agenda for helminth diseases of humans: health research and capacity building in disease-endemic countries for helminthiases control. PLoS Negl Trop Dis (2012) 0.99
Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon. Epilepsia (2003) 0.98
Transmission intensity and the patterns of Onchocerca volvulus infection in human communities. Am J Trop Med Hyg (2002) 0.98
Radiation-induced leukemia at doses relevant to radiation therapy: modeling mechanisms and estimating risks. J Natl Cancer Inst (2006) 0.97
Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon. PLoS Negl Trop Dis (2013) 0.96
Density-dependent effects on the weight of female Ascaris lumbricoides infections of humans and its impact on patterns of egg production. Parasit Vectors (2009) 0.96
Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa. Trop Med Int Health (2007) 0.96
Uptake of Onchocerca volvulus (Nematoda: Onchocercidae) by Simulium (Diptera: Simuliidae) is not strongly dependent on the density of skin microfilariae in the human host. J Med Entomol (2004) 0.95
What are the mechanisms associated with post-ivermectin serious adverse events? Trends Parasitol (2006) 0.95
Radiation organ doses received in a nationwide cohort of U.S. radiologic technologists: methods and findings. Radiat Res (2014) 0.95
Prevalence and causes of vision loss in sub-Saharan Africa: 1990-2010. Br J Ophthalmol (2014) 0.95
Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am J Trop Med Hyg (2010) 0.94
Hispanic Latin America, Spain and the Spanish-speaking Caribbean: a rich source of reference material for public health, epidemiology and tropical medicine. Emerg Themes Epidemiol (2008) 0.94
Ischemic heart disease after breast cancer radiotherapy. N Engl J Med (2013) 0.93
Temporal and micro-spatial heterogeneity in the distribution of Anopheles vectors of malaria along the Kenyan coast. Parasit Vectors (2013) 0.93
Head nodding syndrome and river blindness: a parasitologic perspective. Epilepsia (2009) 0.92
Individual predisposition, household clustering and risk factors for human infection with Ascaris lumbricoides: new epidemiological insights. PLoS Negl Trop Dis (2011) 0.92
Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen. Am J Trop Med Hyg (2013) 0.92
Identifying host species driving transmission of schistosomiasis japonica, a multihost parasite system, in China. Proc Natl Acad Sci U S A (2013) 0.91
Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites. BMC Infect Dis (2011) 0.91
Density dependence and the spread of anthelmintic resistance. Evolution (2007) 0.91
A research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiases. PLoS Negl Trop Dis (2012) 0.91
Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma. Am J Epidemiol (2013) 0.91
Where next with Loa loa encephalopathy? Data are badly needed. Trends Parasitol (2007) 0.90
Sampling strategies to detect anthelmintic resistance: the perspective of human onchocerciasis. Trends Parasitol (2008) 0.90